Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form.
Academic Article
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
The aim of this study was to systematically obtain a model of factors that would yield an optimized self-nanoemulsified capsule dosage form (SNCDF) of a highly lipophilic model compound, Coenzyme Q10 (CoQ). Independent variables such as amount of R-(+)-limonene (X1), surfactant (X2), and cosurfactant (X3), were optimized using a 3-factor, 3-level Box-Behnken statistical design. The dependent variables selected were cumulative percentage of drug released after 5 minutes (Y1) with constraints on drug release in 15 minutes (Y2), turbidity (Y3), particle size (Y4), and zeta potential (Y5). A mathematical relationship obtained, Y1 = 78.503 + 6.058X1 + 13.738X2 + 5.986X3 - 25.831X1(2) + 9.12X1X2 - 26.03 X1X3 - 38.67 X2(2) +11.02X2X3 - 15.55 X3(3) (r2 = 0.97), explained the main and quadratic effects, and the interaction of factors that affected the drug release. Response surface methodology (RSM) predicted the levels of factors X1, X2, and X3 (0.0344, 0.216, and 0.240, respectively), for a maximized response of Y1 with constraints of >90% release on Y2. The observed and predicted values of Y1 were in close agreement. In conclusion, the Box-Behnken experimental design allowed us to obtain SNCDF with rapid (>90%) drug release within 5 minutes with desirable properties of low turbidity and particle size.
